Registro:

Referencias:

• Andrei, G., De Clercq, E., Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro (1990) Antiviral Research, 14, pp. 287-300
• Candurra, N.A., Damonte, E.B., Acción inhibitoria de la cafeína sobre la multiplicación del virus junín (1999) Revista Argentina de Microbiología, 31, pp. 135-141
• Candurra, N.A., Lago, M.J., Maskin, L., Damonte, E.B., Involvement of cytoskeleton in Junin virus multiplication (1999) Journal of General Virology, 80, pp. 147-156
• Candurra, N.A., Maskin, L., Damonte, E.B., Inhibition of arenavirus multiplication in vitro by phenotiazines (1996) Antiviral Research, 31, pp. 149-158
• Cordo, S.M., Candurra, N.A., Damonte, E.B., Myristic acid analogs are inhibitors of Junin virus replication (1999) Microbes and Infection, 1, pp. 609-614
• Djavani, M., Lukashevich, I.S., Sanchez, A., Nichol, S.T., Salvato, M.S., Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5′end (1997) Virology, 235, pp. 414-418
• Enria, D.A., Maiztegui, J.I., Antiviral treatment of Argentine hemorrhagic fever (1994) Antiviral Research, 23, pp. 23-31
• Huang, M., Maynard, A., Turpin, J.A., Graham, L., Janini, G.M., Covell, D.G., Rice, W.G., Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins (1998) Journal of Medicinal Chemistry, 41, pp. 1371-1381
• Iapalucci, S., Lopez, N., Rey, O., Zakin, M.M., Cohen, G.N., Franze-Fernandez, M.T., The 5′region of Tacaribe virus L RNA encodes a protein with a potential metal binding domain (1989) Virology, 173, pp. 357-361
• Martinez Peralta, L.A., Coto, C.E., Weissenbacher, M.C., The Tacaribe Complex: Relationship between a pathogenic (Junin) and a nonpathogenic (Tacaribe) arenavirus (1993) The Arenaviridae, pp. 281-298. , Edited by MS Salvato. New York: Plenum Press
• McKee, K.T., Huggins, J.W., Trahan, C.J., Mahlandt, B.G., Ribavirin prophylaxis and therapy for experimental Argentine hemorrhagic fever (1988) Antimicrobial Agents and Chemotherapy, 32, pp. 1304-1309
• Rice, W.G., Turpin, J.A., Schaeffer, C.A., Graham, L., Clanton, D., Buckheit R.W., Jr., Zaharevitz, D., Covell, D.G., Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 Zinc finger inhibitors (1996) Journal of Medicinal Chemistry, 39, pp. 3603-3616
• Rice, W.G., Baker, D.C., Schaeffer, C.A., Graham, L., Bu, M., Terpening, S., Clanton, D., Turpin, J.A., Inhibition of multiple phases of human immunodeficiency virus type 1 replication by a dithiane compound that attacks the conserved zinc fingers of retroviral nucleocapsid proteins (1997) Antimicrobial Agents and Chemotherapy, 41, pp. 419-426
• Rice, W.G., Turpin, J.A., Huang, M., Clanton, D., Buckheit Rw C.D.G., Jr., Wallquist, A., McDonnell, N.B., Sausville, E.A., Azidocarbamide inhibits hiv-1 replication by targeting the nucleocapsid protein (1997) Nature Medicine, 3, pp. 341-345
• Salvato, M.S., Shimomaye, E.M., The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein (1989) Virology, 173, pp. 1-10
• Saurin, A.J., Borden, K.L.B., Boddy, M.N., Freemont, P.S., Does this have a familiar RING? (1996) Trends in Biochemical Science, 246, pp. 208-213
• Tummino, P.J., Harvey, P.J., McQuade, T., Domagala, J., Gogliotti, R., Sanchez, J., Song, Y., Hupe, D., The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: Correlation with anti-HIV and virucidal activities (1997) Antimicrobial Agents and Chemotherapy, 41, pp. 394-400
• Weissenbacher, M.C., Laguens, R.P., Coto, C.E., Argentine hemorrhagic fever (1987) Currents Topics in Microbiology and Immunology, 134, pp. 79-116
• Witvrouw, M., Balzarini, J., Pannecouque, C., Jhaumeer-Laulloo, S., Esté, J.A., Schols, D., Cherepanov, P., Declercq, E., SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus (1997) Antimicrobial Agents and Chemotherapy, 41, pp. 262-268

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------